Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17996996 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine
Conditions: Meningococcal Infection;   Haemophilus Infection
Interventions: Biological: Hib-MenCY-TT vaccine (MenHibrix);   Biological: Meningitec®;   Biological: ActHIB®;   Biological: Infanrix® Penta;   Biological: Prevenar®;   Biological: Mencevax® ACWY;   Biological: PRP (Polyribosyl Ribitol Phosphate)

Indicates status has not been verified in more than two years